Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Blood Advances|July 16, 2025
Olutasidenib alone or combined with azacitidine in patients with mutant IDH1 myelodysplastic syndromeJorge E Cortes, Jay Yang, Gail J Roboz, et al.
Clinical Hematology International|October 17, 2024
Determinants of Outcomes for Acute Myeloid Leukemia Patients Treated in a Community-Based Specialized Versus Non-Specialized Hospital SettingMinoo Battiwalla, Ju-Hsien Chao, Tonya Cox, et al.
Hematological Oncology|May 7, 2024
A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemiaSudhir Manda, Bertrand M Anz, Christopher Benton, et al.
Clinical and Translational Science|March 18, 2024
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndromeRupa Narayan, Ana Alfonso Piérola, William B Donnellan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2022
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical TrialJesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, et al.
Blood|April 7, 2021
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 resultsBijal D Shah, Michael R Bishop, Olalekan O Oluwole, et al.
Pageof 2